Hosted on MSN13d
Zydus Lifesciences shares in focus after FDA approval for prostate cancer drug
Zydus Lifesciences shares will be in focus on Wednesday after the company secured final approval from the US Food and Drug ...
Longview News-Journal21d
Zynext Ventures invests in Illexcor Therapeutics to advance novel oral therapy for sickle cell disease
Zynext Ventures and Zydus Lifesciences are in a strategic position to help us achieve these goals." Sickle cell disease is a devastating and debilitating genetic condition that affects up to 10 ...